New role further bolsters branding and international marketing operations post Harlan acquisition
Huntingdon (UK), 27 May April 2015: Huntingdon Life Sciences and Harlan Laboratories today announced the appointment of Joseph Bedford, Ph.D. as Corporate Vice President of Global Strategic Marketing. The creation of this new position strengthens the two firms’ international strategic marketing function across its Contract Research Services (CRS) and Research Models Services (RMS) business units. Dr. Bedford’s responsibilities include global marketing, business intelligence, strategic planning and aspects of corporate development. He heads up a global team of 19 staff and is a member of the firm’s Executive Leadership Team.
Prior to joining Huntingdon and Harlan, Dr. Bedford served as Vice President of Global Marketing at Taconic Biosciences, where he implemented a corporate renaming and rebranding initiative, enhanced CRO sales channel strategies and acted as the global lead of the marketing function for research models and services. Dr. Bedford’s other experience includes stints with Covance and the Almac Group covering a twelve year period. While serving as Associate Director of Global Market Research and then Director of Marketing and Strategy at Covance, Dr. Bedford played a key role in supporting decision making on business strategy, market positioning, and corporate development over a period in which Covance doubled its revenues from $800m to $1.7b. As Director of Marketing at the Almac Group, he was responsible for re-positioning the clinical technologies services business unit, helping it grow 4x, and leading the marketing efforts of Almac’s integrated clinical service offerings.
Commenting on Dr. Bedford’s appointment, Dr. Adrian Hardy, Chief Operating Officer at Huntingdon Life Sciences and Harlan Laboratories commented: “We are delighted that Joe has joined the organisation. This is an especially important time for us as we continue to develop the combined, integrated brand of the two companies. Joe’s strong expertise in strategic marketing across both the CRS and RMS CRO space will prove to be a great asset to the organisation, and he brings an experienced new voice to the team.”
Remarking on his appointment, Dr. Bedford said: “I am very pleased to take on this position and look forward to playing my part in rebranding these two market leading companies and their subsidiaries to create a dynamic new firm that is well positioned for future growth. This is an ideal time to join the organization given the enormous potential of the combined entity in the marketplace. We are already seeing the benefits of bringing these businesses together - it is exciting our customers, our employees and all the stakeholders in our new company.”
-ENDS-
Notes to editors
About Huntingdon Life Sciences
Huntingdon Life Sciences is a global provider of non-clinical contract research services to the pharmaceutical, crop protection and chemical industries. Huntingdon Life Sciences is a privately held company. www.huntingdon.com
About Harlan Laboratories
Harlan Laboratories, Inc. is a leading global provider of non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, crop protection and chemical industries, as well as universities, government, and other research organizations. Harlan Laboratories is a privately held company. www.harlan.com
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44 207 203 6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com
Company contacts:
Katie Bramwell at Huntingdon Life Sciences
Phone: +44 (0) 1480 892748 Email: BramwellK@ukorg.Huntingdon.com
Andrew Gay at Huntingdon Life Sciences
Phone: + 44 (0) 1480 893073 Email: Gaya@ukorg.Huntingdon.com
Help employers find you! Check out all the jobs and post your resume.
Huntingdon (UK), 27 May April 2015: Huntingdon Life Sciences and Harlan Laboratories today announced the appointment of Joseph Bedford, Ph.D. as Corporate Vice President of Global Strategic Marketing. The creation of this new position strengthens the two firms’ international strategic marketing function across its Contract Research Services (CRS) and Research Models Services (RMS) business units. Dr. Bedford’s responsibilities include global marketing, business intelligence, strategic planning and aspects of corporate development. He heads up a global team of 19 staff and is a member of the firm’s Executive Leadership Team.
Prior to joining Huntingdon and Harlan, Dr. Bedford served as Vice President of Global Marketing at Taconic Biosciences, where he implemented a corporate renaming and rebranding initiative, enhanced CRO sales channel strategies and acted as the global lead of the marketing function for research models and services. Dr. Bedford’s other experience includes stints with Covance and the Almac Group covering a twelve year period. While serving as Associate Director of Global Market Research and then Director of Marketing and Strategy at Covance, Dr. Bedford played a key role in supporting decision making on business strategy, market positioning, and corporate development over a period in which Covance doubled its revenues from $800m to $1.7b. As Director of Marketing at the Almac Group, he was responsible for re-positioning the clinical technologies services business unit, helping it grow 4x, and leading the marketing efforts of Almac’s integrated clinical service offerings.
Commenting on Dr. Bedford’s appointment, Dr. Adrian Hardy, Chief Operating Officer at Huntingdon Life Sciences and Harlan Laboratories commented: “We are delighted that Joe has joined the organisation. This is an especially important time for us as we continue to develop the combined, integrated brand of the two companies. Joe’s strong expertise in strategic marketing across both the CRS and RMS CRO space will prove to be a great asset to the organisation, and he brings an experienced new voice to the team.”
Remarking on his appointment, Dr. Bedford said: “I am very pleased to take on this position and look forward to playing my part in rebranding these two market leading companies and their subsidiaries to create a dynamic new firm that is well positioned for future growth. This is an ideal time to join the organization given the enormous potential of the combined entity in the marketplace. We are already seeing the benefits of bringing these businesses together - it is exciting our customers, our employees and all the stakeholders in our new company.”
-ENDS-
Notes to editors
About Huntingdon Life Sciences
Huntingdon Life Sciences is a global provider of non-clinical contract research services to the pharmaceutical, crop protection and chemical industries. Huntingdon Life Sciences is a privately held company. www.huntingdon.com
About Harlan Laboratories
Harlan Laboratories, Inc. is a leading global provider of non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, crop protection and chemical industries, as well as universities, government, and other research organizations. Harlan Laboratories is a privately held company. www.harlan.com
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44 207 203 6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com
Company contacts:
Katie Bramwell at Huntingdon Life Sciences
Phone: +44 (0) 1480 892748 Email: BramwellK@ukorg.Huntingdon.com
Andrew Gay at Huntingdon Life Sciences
Phone: + 44 (0) 1480 893073 Email: Gaya@ukorg.Huntingdon.com
Help employers find you! Check out all the jobs and post your resume.
